User contributions
From OncoWiki
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 13:06, 14 June 2017 (diff | hist) . . (+931) . . N BeGeV (Created page with "== Hodgkin disease == salvage regimen in relapsed Hodgkin's lymphoma == Regimen == phase II study * Gemcitabine 800 mg/m2 on days 1 and 4 * Vinorelbine 20 mg/m2 on day 1, *...") (current)
- 12:57, 14 June 2017 (diff | hist) . . (+14) . . Lymphoma Hodgkin's, Adult (→Salvage) (current)
- 02:03, 21 September 2016 (diff | hist) . . (+593) . . Flu Bu ATG - Slavin (current)
- 02:02, 21 September 2016 (diff | hist) . . (+316) . . N Flu Bu ATG - Slavin (Created page with "*Fludarabine (Fludara) 30 mg/m<sup>2</sup> IV once per day on days -10 to -5 (6 consecutive days) *Busulfan (Myleran) 4 mg/kg/day PO on days -6 to -5 (2 consecutive da...")
- 01:55, 21 September 2016 (diff | hist) . . (+1) . . m Stem Cell Transplantation (→Non-myeloablative conditioning regimens) (current)
- 01:54, 21 September 2016 (diff | hist) . . (+23) . . Stem Cell Transplantation (→Non-myeloablative conditioning regimens)
- 20:21, 6 July 2016 (diff | hist) . . (+2,303) . . N Flu Bu ATG for Haplo (Created page with "== Regimen == *Busulfan (Busulfex, Otsuka Pharmaceuticals) 3.2 mg/kg per day intravenously on days −7 and −6 *Fludarabine 30 mg/m2 per day intravenously on days −7 to...") (current)
- 20:07, 6 July 2016 (diff | hist) . . (+1) . . m Stem Cell Transplantation (→Non-myeloablative conditioning regimens)
- 20:06, 6 July 2016 (diff | hist) . . (+25) . . Stem Cell Transplantation (→Non-myeloablative conditioning regimens)
- 21:52, 16 May 2016 (diff | hist) . . (+1,666) . . N R-MPV (Created page with "== Regimen == IV Rituximab 500 mg/m2 day 1 IV Methotrexate 3.5 mg/m2 (over 2hours) day 2 IV Vincristine 1.4 mg/m2 (capped at 2.8mg)day 2 Procarbazine 100 mg/m2 /day was gi...") (current)
- 21:45, 16 May 2016 (diff | hist) . . (+4) . . m Lymphoma Non-Hodgkin's, Adult (→Primary CNS Lymphoma) (current)
- 21:44, 16 May 2016 (diff | hist) . . (+10) . . Lymphoma Non-Hodgkin's, Adult (→Primary CNS Lymphoma)
- 02:18, 18 April 2016 (diff | hist) . . (+1,734) . . N VDT-PACE (VDTPACE) (current)
- 01:50, 18 April 2016 (diff | hist) . . (+1) . . m Multiple Myeloma And Plasma Cell Dyscrasias (→Combinations) (current)
- 01:50, 18 April 2016 (diff | hist) . . (+13) . . m Multiple Myeloma And Plasma Cell Dyscrasias
- 22:01, 1 May 2014 (diff | hist) . . (+35) . . m Lymphoma Non-Hodgkin's, Adult (→Aggressive NHL)
- 21:54, 1 May 2014 (diff | hist) . . (+113) . . m Brentuximab vedotin (→Brentuximab vedotin (Adcetris)) (current)
- 21:53, 1 May 2014 (diff | hist) . . (+1,048) . . m Brentuximab vedotin (→Regimen)
- 21:50, 1 May 2014 (diff | hist) . . (+334) . . N Brentuximab vedotin (Created page with "==Brentuximab vedotin (Adcetris)== ===Regimen=== *Brentuximab vedotin (Adcetris) 1.8 mg/kg IV over 30 minutes on day 1 Supportive medications: *Rothe et al. 2012: "no p...")
- 21:49, 1 May 2014 (diff | hist) . . (+28) . . m Lymphoma Hodgkin's, Adult (→Salvage)
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
